Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.420
+0.060 (4.41%)
At close: Jun 27, 2025, 4:00 PM
1.390
-0.030 (-2.11%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Cerus Employees
As of December 31, 2024, Cerus had 630 total employees, including 614 full-time and 16 part-time employees. The number of employees decreased by 7 or -1.10% compared to the previous year.
Employees
630
Change (1Y)
-7
Growth (1Y)
-1.10%
Revenue / Employee
$293,879
Profits / Employee
-$30,075
Market Cap
271.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CERS News
- 15 days ago - Cerus Corporation Celebrates World Blood Donor Day 2025 - Business Wire
- 25 days ago - Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Business Wire
- 4 weeks ago - Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Business Wire
- 4 weeks ago - Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device - Business Wire
- 2 months ago - Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cerus Corporation Announces First Quarter 2025 Financial Results - Business Wire
- 2 months ago - Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 - Business Wire
- 4 months ago - Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200) - Business Wire